Soydinc, Hatice EnderSak, Muhammet ErdalEvliyaoglu, OsmanEvsen, Mehmet SiddiTurgut, AbdulkadirOzler, AliTay, Hayrettin2024-04-242024-04-2420121309-03991309-0380https://doi.org/10.5152/jtgga.2012.23https://search.trdizin.gov.tr/yayin/detay/158705https://hdl.handle.net/11468/19979Objective: This study aimed to investigate the role of various biochemical markers in preterm premature rupture of membranes (PPROM) and in prediction of chorioamnionitis in patients with PPROM. Material and Methods: This case-control study included a total of 100 pregnant women at 26-34 gestational weeks. Of these women, 50 were healthy and 50 had PPROM. The biochemical markers in the maternal plasma including prolidase, matrix metalloproteinase (MMP) 1 and 13, total oxidative status (TOS), total antioxidant capacity (TAC), glutathione peroxidase (GPx), catalase (CAT), paraoxonase-1 (PON-1), tumor necrosis factor alpha (TNF-alpha), and high sensitive C-reactive protein (hsCRP) were assayed. These levels were compared between the PPROM and control groups and between women with or without chorioamnionitis in the PPROM group. Results: Compared to the control group, the levels of prolidase, MMP13, and TOS were significantly higher (p values < 0.001, 0.020, and 0.035, respectively) and those of TAC and PON-1 were significantly lower in the maternal plasma of the PPROM group (p values= 0.012 and < 0.001, respectively). The plasma prolidase and TOS levels were significantly higher (p values= 0.033 and 0.005, respectively) and the plasma TAC and PON-1 levels were significantly lower in women with chorioamnionitis as compared with the corresponding values in women without chorioamnionitis in the PPROM group (p values = 0.041 and 0.048, respectively). The multivariate logistic regression analysis observed that prolidase, TAC, and PON-1 were important markers for the presence of PPROM and prolidase and TOS were important markers for predicting chorioamnionitis. Conclusion: This study suggested that maternal plasma prolidase, TAC, and PON-1 may be useful for the diagnosis of PPROM, and prolidase and TOS may be used to predict chorioamnionitis in patients with PPROM.eninfo:eu-repo/semantics/openAccessPreterm Premature Rupture Of MembranesMaternal PlasmaProlidaseMatrix MetalloproteinaseOxidative StressArticle133172177WOS:0004206528000062-s2.0-848660017161587052459203310.5152/jtgga.2012.23Q3N/A